The decline in the cost per based pair of NGS data acquisition plus assay and informatic innovation continue to expand the scope of questions that oncology diagnostic testing can address.

We continuously improve our Seraseq reference material offerings to match the needs of the community such as accurate detection of complex structural variants, specificity assessments and sensitivity. Dive into customer data from our recently updated solid tumor, liquid biopsy and inherited cancer reference materials. Following the data presentation, access the roundtable discussion on unmet QMS needs in the community.